• Wearable Devices holds a first-mover advantage in AI-powered neural input wearables, with validation from CES Innovation Awards and early adoption in key markets.
• The company operates a dual-channel strategy that targets both consumer product sales and enterprise licensing opportunities.
• Strategic partnerships with Qualcomm, TCL-RayNeo(TM), and Media Exceed support the company’s efforts to scale commercialization globally.
• Its expanding patent portfolio includes recent U.S. approvals for gesture-based and hybrid voice control technologies, reinforcing its competitive edge.
• With active initiatives in XR, spatial computing, and predictive health monitoring, the company is positioned to benefit from multiple high-growth sectors.

Wearable Devices (NASDAQ: WLDS) is a growth-stage technology company pioneering the next generation of human-computer interaction through AI-powered neural input wearables. Mudra, its proprietary wrist-worn technology, enables touchless, gesture-based control of digital devices, offering users a seamless, intuitive interface through subtle finger and hand movements. Since introducing its technology to the market in 2014, the company has pursued both business-to-business (B2B) and business-to-consumer (B2C) strategies through a dual-channel model.

The company believes the future of technology should begin with the human. Wearable Devices envisions decoding the human body to enable context-aware AI-powered technology that listens, learns, and adapts – to us.

The company envisions a future where human intent becomes the language of technology. Through non-invasive neural sensing and adaptive algorithms, the company enables more natural, personalized, and intuitive interactions with computers.

The company is headquartered in Yokneam Illit, Israel.

Products

Neural control has entered the market: commercially available since 2023 with the Mudra Band and already used by thousands of users worldwide. With its product line, including Mudra Band and Mudra Link, the company has introduced the world’s first wrist-worn neural interfaces, enabling intuitive, touchless control through natural micro-gestures: subtle finger movements and wrist flicks. Whether streaming media, controlling smart devices, or interacting with AR glasses, Mudra brings neural input into everyday life.

This early adoption isn’t just validation — it’s acceleration. With real users engaging in real environments, the company is learning fast, improving faster, and shaping a product that grows more refined with every interaction.

Mudra Band

Mudra Band is the company’s flagship B2C product, designed as a sleek, aftermarket accessory for the Apple Watch. It uses patented sEMG sensors to detect neural signals from the wrist and translates them into real-time digital commands. This allows users to control and streamline interactions between the iPhone, iPad, MacBook, and Apple TV using familiar micro-gestures like taps, pinches, or swipes — all without touching a screen.

The device features a high-resolution analog front end, IMU integration, adaptive machine learning, and ergonomic form factors for all-day comfort. Users can toggle between multiple Apple devices using the Mudra Band’s dedicated Apple Watch face, enabling a fully connected, touchless experience. The Mudra Band is optimized for low-latency, high-accuracy interactions and supports a wide range of digital applications. The Mudra Band received a CES 2021 Innovation Award.

Mudra Link

Mudra Link expands the company’s reach beyond the Apple ecosystem, offering compatibility with Android, Windows, and AR/XR platforms. The product includes the innovative Gesture Mapper feature, allowing users to assign personalized commands to gestures such as tap, pinch, flick, or twist. This functionality replaces or augments traditional input methods, supporting media controls, pointer input, and full directional mapping. A key feature of Mudra Link is its dual-mode input system (mouse mode or D-pad mode), empowering users to personalize control schemes across devices, operating systems, and user interfaces.

Mudra Link is recognized for its ergonomic design, lightweight build, and plug-and-play ease of use. It supports native integration with AR glasses from leading manufacturers and received a CES 2025 Innovation Award.

Mudra DevKit and Integration

In parallel with its consumer devices, Wearable Devices offers a Mudra Developer Kit (MDK) and integration program for enterprise and OEM partners. The MDK includes full-stack tools (hardware bands, SDK, APIs, and sample code) that allow developers and original equipment manufacturers to embed Mudra’s neural sensing capabilities into their own products and applications. For example, an AR headset maker can integrate Mudra’s sensors to enable native hand-gesture input, or a software developer can use Mudra’s API to track user gestures for novel interactions.

The MDK supports both Android and iOS and even provides real-time neural raw signal monitoring for research and prototyping. This B2B offering not only expands Mudra technology into new environments such as industrial automation, robotics, and gaming peripherals, but also fosters a broader ecosystem of Mudra-powered solutions. By lowering the barrier for others to adopt its AI gesture recognition engine, Wearable Devices accelerates innovation and garners strategic relationships.

The MDK and related licensing offerings illustrate Wearable Devices’ push-pull strategy: selling consumer products today, while seeding ‘Mudra inside’ into other companies’ devices tomorrow.

Market Opportunity & Strategy

Wearable Devices operates at the intersection of neural interfaces, wearable computing, and the rapidly expanding AR/XR sector. According to MarketsandMarkets, the global AR and VR market is projected to grow from $22.12 billion in 2024 to $96.32 billion by 2029, at a CAGR of 34.2%. The rising demand for natural, hands-free input methods positions neural wearables like Mudra as foundational components in spatial computing and smart environments.

Additionally, the health monitoring wearables market is gaining traction as neural biosignals become a promising data source. The company’s LMM (Large Motor Unit Action Potential Model) platform is being explored for predictive health monitoring, cognitive state tracking, and performance analytics. Government-level support, such as advocacy from the U.S. Secretary of Health and Human Services, further validates the sector’s momentum.

Combined with patent-protected technology and strategic alliances with companies like Qualcomm, TCL-RayNeo(TM), and Media Exceed, Wearable Devices is well-positioned to capture value across consumer, enterprise, and healthcare verticals.

The company’s phased market strategy anticipates this:

• Phase 1 – Enthusiast Consumer Adoption: Introduce Mudra Band as an add-on for Apple Watch (tapping into a passionate user base of early adopters and tech enthusiasts). Achieve proof-of-concept and get market feedback. This phase built brand credibility and seeded a community of users.
• Phase 2 – Expand Platform & Ecosystem: Launch Mudra Link for all users and open the Mudra SDK to developers and B2B partners. Focus on the XR/AR market and tech-savvy consumers, while enabling enterprise use-cases through the Developer Kit and strategic partnerships. The company is actively showcasing its tech to industry leaders and integrating with their platforms.
• Phase 3 – Leverage Data & Enter New Verticals: With a growing user base, Wearable Devices is collecting an invaluable dataset of neural signals and usage patterns. If data is the new oil for AI, neural signals will power the next computing revolution — enabling machines to understand human intent in real time. This fuels its Large Motor-Unit Action Potential Model (LMM) – a bio-signal intelligence platform that continuously learns from neural data to improve accuracy and enable new applications. One major new vertical is digital health and wellness: Wearable Devices is adapting its tech to track physiological and cognitive indicators from the wrist. Because the Mudra sensors capture muscle activation signals, they can potentially detect patterns related to stress, fatigue, focus, and even early signs of health conditions before traditional symptoms appear, and Wearable Devices recently announced it is expanding LMM into predictive health monitoring and cognitive analytics. This means the company could offer solutions for workplace productivity (measuring alertness), athletic training (muscle fatigue analytics), or preventive healthcare (flagging neuromuscular irregularities) – vastly broadening its addressable market. Through monitor applications, the vision is to go from controlling devices to also understanding the user, providing actionable bio-insights. The LMM platform’s AI continuously adapts to each individual’s neural profile, enabling truly personalized and proactive applications.
• Phase 4 – Ubiquitous Adoption via B2B Integration: Finally, Wearable Devices plans to drive mass adoption by aligning with major consumer tech players. By making its Mudra Data Platform available to enterprises, OEMs, and app developers, the company positions itself as the backbone for neural interaction services. By “laying the groundwork for the next neural frontier”, Wearable Devices is ensuring that when the tech giants move to adopt neural input, its platform is the mature, data-rich standard ready to be deployed.

Through these phased efforts, Wearable Devices balances B2C and B2B paths. It generates near-term revenues and user feedback via direct consumer product sales, while simultaneously developing long-term enterprise relationships and intellectual property value. This dual model not only diversifies revenue streams but also reinforces the technology’s credibility: consumer adoption demonstrates demand and usability, which in turn attracts enterprise interest, creating a virtuous cycle.

Leadership Team

Asher Dahan, Chief Executive Officer, co-founded Wearable Devices Ltd. in 2014 and has served as CEO and director since 2016. He is a seasoned executive with proven expertise in strategic planning, project execution, and business leadership. Asher oversees the company’s operations and resources, guiding major corporate decisions and long-term vision. Prior to founding Wearable Devices, he held engineering and leadership roles at Intel Haifa, specializing in high-speed interface validation. He holds a BSc in Electrical Engineering from Ort Braude College.

Guy Wagner, Chief Scientific Officer and President, co-founded Wearable Devices Ltd. in 2014 and has served on its board since inception. As CSO and President, Guy leads the company’s technological innovation and scientific direction. He is the main inventor behind the company’s core technology and brings multidisciplinary expertise in hardware design, biomedical signal processing, embedded programming, and sensor systems. He previously worked at Intel as a hardware engineer and holds a BSc in Electrical Engineering from Ort Braude College.

Leeor Langer, co-founder and CTO since 2016, is a leading expert in algorithms, machine learning, and signal and image processing. He has held senior R&D roles in the medical imaging and digital security sectors, including at Intel, and brings deep academic and industry experience. Leeor has authored several scientific papers and holds a BSc from the Technion and an MSc in Applied Mathematics from Tel Aviv University, graduating cum laude.

For more information, visit the company’s website at https://wwwearabledevices.co.il.

NOTE TO INVESTORS: The latest news and updates relating to WLDS are available in the company’s newsroom at https://ibn.fm/WLDS

• ONAR’s acquisition of Retina.ai adds proven customer lifetime value prediction technology trusted by Unilever and Dollar Shave Club to enhance the company’s Cortex platform capabilities
• Appointment of former MDC Partners Chairman & CEO Scott Kauffman as Board Chairman signals aggressive growth strategy and M&A focus for the marketing technology network
• Addition of cybersecurity and AI expert Mark Gazit to the board strengthens technical leadership as ONAR scales its AI-driven marketing solutions across middle-market clients

The marketing technology landscape is experiencing a consolidation wave that extends far beyond typical industry cycles. As digital marketing becomes increasingly complex and data-driven, companies face mounting pressure to deliver measurable results while navigating privacy regulations, attribution challenges, and rapidly evolving consumer behaviors. The winners in this environment are emerging as those organizations that can combine deep technical capabilities with proven marketing expertise, creating integrated platforms that deliver both immediate performance and long-term strategic value.

However, building these capabilities organically requires significant time and resources that many marketing technology companies simply don’t possess. The alternative, acquiring proven technologies and integrating them with existing platforms, offers a faster path to market leadership, but only for companies with the vision to identify the right targets and the execution capability to realize synergies.

This strategic imperative has created opportunities for marketing technology companies that can move decisively to acquire complementary technologies while simultaneously strengthening their leadership teams with executives who understand both the technical and business dimensions of platform scaling.

That convergence of acquisition strategy and leadership enhancement is exactly what ONAR Holding Corp. (OTCQB: ONAR) has executed through a series of strategic moves positioning the company for accelerated growth in the AI-driven marketing technology sector.

Strategic Acquisition Enhances Core AI Capabilities

ONAR’s definitive agreement to acquire Retina.ai represents more than a typical technology acquisition; it’s a strategic move to integrate proven customer intelligence capabilities directly into the company’s core platform architecture. Retina.ai brings AI-powered marketing intelligence that predicts customer lifetime value early in the customer lifecycle, enabling brands to optimize marketing spend before a campaign is launched rather than after results are measured.

The acquisition’s strategic value lies in Retina.ai’s established client roster, including major consumer brands like Unilever, Dollar Shave Club, quip, Madison Reed, and Liquid I.V. These relationships validate the platform’s effectiveness at enterprise scale and provide immediate proof points for ONAR’s enhanced capabilities.

More importantly, ONAR plans to merge Retina.ai with its existing Cortex platform, creating an integrated system that combines real-time campaign optimization with predictive customer value modeling. This integration addresses a critical gap in marketing technology: the ability to predict customer value before acquisition costs are incurred, enabling more precise targeting and budget allocation.

“Integration and measurement are the bedrock of smart marketing,” noted CEO Claude Zdanow. “Retina.ai is a jewel in our tech stack. Combining it with Cortex sharpens our targeting, accelerates our growth initiatives, and ultimately magnifies long-term shareholder value.”

The acquisition also opens new revenue streams through Retina.ai’s SaaS subscription model, which can be deployed across ONAR’s existing client base while attracting new customers seeking advanced customer intelligence capabilities.

Leadership Appointments Signal Aggressive Growth Strategy

ONAR’s appointment of Scott Kauffman as Board Chairman represents a strategic inflection point that signals the company’s intention to accelerate growth through both organic expansion and acquisitions. Kauffman brings over three decades of executive experience, including his transformative leadership as Chairman and CEO of MDC Partners, where he orchestrated the company’s combination with Stagwell Marketing Group to create Stagwell Inc., a $3+ billion global marketing powerhouse.

His appointment is particularly significant given his track record in scaling marketing technology platforms and executing complex transactions. At MDC Partners, Kauffman demonstrated the ability to navigate the marketing industry’s consolidation while building integrated capabilities that serve middle-market clients, exactly the segment ONAR targets.

“ONAR has already laid the foundation for something truly differentiated,” Kauffman stated upon his appointment. “The company’s focus on technology-enabled marketing solutions for mid-sized brands is exactly where the future is headed.”

Complementing Kauffman’s appointment, ONAR added Mark Gazit to its Board of Directors, bringing globally recognized expertise in cybersecurity and artificial intelligence. Gazit co-founded ThetaRay in 2013 and served as CEO for a decade, scaling the company into a worldwide leader in AI-driven financial crime detection solutions.

Gazit’s background provides critical technical leadership as ONAR scales its AI capabilities across its agency network. His experience building and scaling AI-driven platforms offers strategic insight into the technical challenges facing marketing technology companies as they integrate machine learning capabilities across complex client environments.

Integrated Platform Strategy Creates Market Differentiation

The combination of strategic acquisition and enhanced leadership positions ONAR to execute on its vision of creating an integrated marketing technology platform specifically designed for middle-market companies. Unlike enterprise-focused solutions that require significant internal resources to implement and manage, ONAR’s approach combines technological capabilities with full-service agency support.

This integrated model addresses a critical market need: middle-market companies that require sophisticated marketing technology capabilities but lack the internal resources to manage complex platforms independently. By combining Retina.ai’s predictive analytics with Cortex’s optimization capabilities and delivering these through its agency network, ONAR creates a comprehensive solution that competitors struggle to replicate.

The strategic timing of these moves appears well-positioned to capitalize on broader market trends. As privacy regulations limit traditional targeting methods and marketing budgets face increased scrutiny, companies need more sophisticated approaches to customer acquisition and retention. ONAR’s enhanced platform addresses these challenges by providing predictive insights that enable more efficient marketing spend allocation.

Market Positioning for Accelerated Growth

ONAR’s recent strategic moves position the company to capture significant market share as marketing technology consolidation accelerates. The company’s focus on middle-market clients, combined with its integrated technology and service delivery model, creates a differentiated market position that larger enterprise-focused competitors often overlook.

The addition of proven customer intelligence capabilities through the Retina.ai acquisition, combined with leadership expertise in scaling marketing technology platforms, provides ONAR with the foundation needed to execute aggressive growth strategies both organically and through additional acquisitions.

As CEO Zdanow noted regarding Kauffman’s appointment: “This landmark appointment represents a defining moment for ONAR. Scott’s leadership experience across global marketing platforms and his sharp eye for scaling disruptive companies make him an ideal fit as we push toward the next phase of growth.”

The convergence of strategic acquisition, enhanced leadership, and integrated platform capabilities positions ONAR to accelerate its growth trajectory in the rapidly evolving marketing technology landscape.

For more information, visit the company’s website at www.ONAR.com.

NOTE TO INVESTORS: The latest news and updates relating to ONAR Holding Corp. are available in the company’s newsroom at https://ibn.fm/ONAR

• A recently posted editorial pointed to optimism for the mine development strategy that ESGold is pursuing, involving prioritizing accessible revenue generation over more speculative mining exploration
• ESGold is approaching the gold and silver market in a unique way, working to first rehabilitate an established legacy mine site in Quebec, generating sufficient capital to proceed with a deeper exploration strategy at a future date
• ESGold expects to generate significant revenue during the first few years of operation by recovering known metals and minerals that can be repurposed profitably
• The company has already conducted a non-invasive, cost-effective Ambient Noise Tomography (ANT) survey that resulted in a report this month indicating open potential at depth both vertically and laterally for ESGold’s eventual plans for exploration at the legacy site

Gold and silver resource developer ESGold (CSE: ESAU) (OTCQB: ESAUF) was featured in an editorial published this month, drawing attention to the company’s low-risk, nature-friendly, revenue-first strategy for developing abandoned mine operations into profitable enterprises.

While junior miners generally engage in speculative exploration that requires significant infusions of capital, ESGold has opted for a different approach that builds a revenue stream from readily accessible mine waste and other resources. That revenue can then be reinvested at a future point in exploration at sites abandoned by prior operators who lacked the necessary resources to fully realize their potential, according to a summary of the editorial.

“With gold prices at historic highs and demand for minerals across the board surging, this is an opportune moment for experienced, well-capitalized companies to secure their place in a revitalized market,” it states (https://ibn.fm/uiXy6).

ESGold’s operation is taking place at its fully permitted Montauban mine site in Quebec, Canada’s second-most populous province, with easy access to the nearby capital city.

The company is preparing to begin a toxic tailings cleanup later this year that will extract gold, silver, and mica.

“We have the capacity to generate on our first four, five years, close to $350 million on this low-hanging fruit (the tailings mineral cleanup and reuse), with almost zero cost,” Chief Operating Officer and former CEO Paul Mastantuono said last month during an interview with the Exploring Mining Podcast.

The company remains committed to the idea of future exploration at the site to further develop its gold producing potential. On July 11, ESGold announced the results of its Ambient Noise Tomography (“ANT”) survey, which revealed that Montauban may be far more than a single deposit.

“It is emerging as a deep, district-scale system with possible structural and geological continuity,” Director André Gauthier stated in the news release (https://ibn.fm/cjlJn).

More than 2.6 million short tons of gold, silver, lead and zinc were mined at the site under previous exploration between 1910 and the 1970s before the site was abandoned. The ANT survey analyzed deep crustal structures across a segment of the property using ambient seismic noise and 105 triaxial sensors continuously recording data.

For more information, visit the company’s website at https://esgold.com.

NOTE TO INVESTORS: The latest news and updates relating to ESAUF are available in the company’s newsroom at https://ibn.fm/ESAUF

• Club valuation rose 245% during the 2024/25 season, as Brera plans for continued growth.
• Juve Stabia adds experienced head coach Ignazio Abate and extends Sporting Director Matteo Lovisa’s contract following a playoff run in 2024/25.
• Squad reinforcements include top-performing goalkeeper Alessandro Confente and striker Tomi Petrovic.
• Player sales, including Andrea Adorante’s transfer to Venezia, contribute to Juve Stabia’s financial and valuation growth.
• Brera views Juve Stabia as a scalable asset aligned with its long-term value creation strategy.

Brera Holdings (NASDAQ: BREA), an Ireland-based international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership (“MCO”) strategy, announced that portfolio club SS Juve Stabia is preparing for the 2025/26 Serie B season with a revamped coaching staff and key player signings This follows a standout 2024/25 campaign that saw the team finish fifth in the table and reach the semifinals of the Serie A promotion playoffs, driving rising valuation (https://ibn.fm/JpvLB). 

The club has appointed former Italian national team player Ignazio Abate as head coach. Abate, who spent the bulk of his career at AC Milan and one season at Napoli, is viewed as one of Italy’s most promising managerial prospects. His appointment signals Juve Stabia’s intent to build on its recent success with an emphasis on disciplined play and player development.

Sporting Director Matteo Lovisa, who built last season’s high-performing roster, has renewed his contract for two additional years. His decision to stay, despite interest from other clubs, provides critical continuity as Juve Stabia aims to push deeper into promotion contention.

Player moves also reflect an aggressive offseason strategy. The club secured goalkeeper Alessandro Confente, widely regarded as the top goalkeeper in Serie C last year, along with experienced right-back Lorenzo Carissoni and striker Tomi Petrovic. These additions come alongside the return of several loaned-out players and the sale of key forward Andrea Adorante to Venezia after a prolific 30-goal stint with Juve Stabia. That transfer, in particular, generated a significant capital gain for the club.

These moves follow a notable increase in the club’s overall valuation. During the 2024/25 season, Juve Stabia’s squad value surged 245%, rising from $9.3 million to $32.3 million. The club posted the highest market value growth in Italy’s Serie B, with performance on the pitch and a rising fan base both contributing to the boost (https://ibn.fm/bkumB). 

“This extraordinary growth reflects both the untapped potential of Juve Stabia and Brera’s value-creation strategy in action,” said Daniel McClory, Executive Chairman of Brera Holdings. McClory emphasized the company’s focus on operational alignment, talent development, and performance-led asset appreciation.

Brera Holdings completed its 52% majority acquisition of SS Juve Stabia on June 20, 2025, marking the formal close of a deal that began in December 2024 with an agreement to purchase the stake from XX Settembre srl, led by club President Andrea Langella. Brera’s multi-club ownership strategy centers on acquiring clubs like Juve Stabia, those with historical relevance, committed local support, and measurable upside in player value and sporting performance.

The team’s preseason began July 10 in Castel di Sangro, and Juve Stabia will kick off its 2025/26 campaign with a Coppa Italia Frecciarossa match against Serie A side Lecce on August 15 at the Stadio Via del Mare.

For more information, visit the company’s website at www.BreraHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to BREA are available in the company’s newsroom at https://ibn.fm/BREA

• The company has recently rebranded and adopted a new strategic direction focused on AI-powered customer acquisition and automated sales engagement.
• Its proprietary platform enables human-like prospecting and communication at scale across multiple industries, including healthcare, biotech, insurance, and transportation.
• AI Maverick is executing a roll-up strategy aimed at acquiring and optimizing revenue-generating businesses with strong growth potential.
• The company is positioned within the AI in marketing sector, which is projected to grow from $20.44 billion in 2024 to $82.23 billion by 2030 at a 25.0% CAGR, according to Grand View Research.
• The platform’s ability to automate both transactional and consultative sales processes gives it a competitive edge in industries where speed and personalization are critical.

AI Maverick Intel (OTC: BINP) is a technology-forward company focused on transforming how businesses acquire and engage customers through artificial intelligence. With a growth strategy centered on acquiring revenue-generating businesses, the company leverages its proprietary platform to deliver scalable, automated solutions across key sectors including healthcare, biotech, insurance, and transportation.

The company’s vision is to eliminate friction from the customer acquisition process by replacing traditional, resource-heavy outreach with intelligent, automated engagement. Its mission is to empower organizations to connect with their ideal audiences at high velocity, using real-time insights and personalized communication powered by machine learning.

AI Maverick Intel is committed to creating long-term value through innovation, efficiency, and strategic partnerships that enhance operational performance and accelerate growth.

The company is headquartered in Dallas, Texas.

Platform & Operations

AI Maverick’s proprietary technology powers a fully automated, AI-driven prospecting engine that enables businesses to scale customer acquisition without expanding headcount. In July 2025, the company launched its enhanced platform, capable of managing both transactional and consultative sales engagements with human-like fluency.

Key components include:

• Comprehensive Contact Intelligence – Aggregates millions of structured and unstructured data points to build dynamic profiles highlighting job changes, buying intent, and preferences.
• Context-Aware Messaging – Adaptive language models tailor tone, timing, and delivery channel for each interaction to maximize engagement.
• Autonomous Sales Dialogues – Manages discovery questions, handles objections, and schedules follow-ups, traditionally handled by sales reps.

This solution supports two-way communication across the full sales funnel—from quote generation and renewals to needs analysis and solution recommendations. The platform is designed to accelerate deal flow and reduce acquisition costs, with typical deployments completed in under a day.

AI Maverick’s transition into an AI-first company followed its acquisition of the AI Maverick platform in May 2025 and a formal rebrand later that month. The company’s public identity now aligns with its operational direction, targeting continued growth through platform scale and strategic business combinations.

Market Opportunity

AI Maverick Intel operates within the rapidly growing artificial intelligence in marketing sector, where machine learning is being widely adopted to personalize customer engagement, optimize ad performance, and automate sales interactions. According to Grand View Research, the global AI in marketing market was valued at $20.44 billion in 2024 and is projected to reach $82.23 billion by 2030, representing a compound annual growth rate (“CAGR”) of 25.0% from 2025 to 2030.

This growth is being driven by increased demand for individualized consumer experiences, expanded adoption of social networking platforms, and the continued rise of online shopping. North America currently leads the market with a 32.4% revenue share, while Asia Pacific is expected to see the fastest growth. Key applications include content curation, dynamic ad creation, and real-time audience targeting, which are consistent with the platform’s intended use cases.

As companies across industries prioritize speed, accuracy, and scale in reaching their target audiences, AI Maverick’s automation-first approach positions it to capitalize on a multi-billion-dollar transformation in how modern customer acquisition is executed.

Leadership Team

Wayne Cockburn, Chief Executive Officer, is an experienced business executive with over 25 years of board experience across public and private companies in both the U.S. and Canada. He has held senior leadership roles in healthcare and financial services firms, with past titles including Executive Vice President at MedX Health Corp., Chairman of Niiomed Inc., and President of Pathway Health Corp. He is skilled in M&A, capital markets, governance, and startup development, and holds a bachelor’s degree from York University’s Glendon College.

For more information, visit the company’s website at https://aimaverickintel.com.

NOTE TO INVESTORS: The latest news and updates relating to BINP are available in the company’s newsroom at https://ibn.fm/BINP 

• Some 50 PGA TOUR professionals now play Newton shafts, validating the company’s rapid growth and elite performance standards.
• Tour winners such as Miguel Ángel Jiménez, Doug Barron and Ken Duke credit Newton’s shafts for delivering superior control, distance and consistency.
• The Fast Motion shaft, Newton’s latest innovation, continues to gain momentum with lightweight precision performance and increasing Tour adoption.

Newton Golf Company (NASDAQ: NWTG) has hit a major milestone in its mission to redefine golf shaft performance — more than 50 professionals across the PGA TOUR Champions and LPGA Tour have now used Newton shafts in competition (https://ibn.fm/5Mcdq). This marks a significant leap from earlier in the season, reflecting growing trust from elite players who value precision, consistency and innovation.

One of Newton’s most impactful endorsements came when Ken Duke became the first professional to officially sign with the brand, integrating the Newton Motion shaft into his bag for the 2024 season (https://ibn.fm/Q9jDe). His standout performance, ranking no. 1 in driving accuracy at the Constellation FURYK & FRIENDS (https://ibn.fm/V2aFq), highlighted the shaft’s consistency and power. “It’s unbelievable how I can shape it,” Duke said. “Not only that, but I’ve gained 6–15 yards with it.”

Duke introduced the shaft to fellow PGA TOUR Champions standout Doug Barron, who then made headlines by winning the 2024 Regions Tradition, his first major title, using Newton Motion (https://ibn.fm/TW96N). Barron saw “tighter dispersion and five more yards” after switching, which gave him “the confidence to win my first major championship.”

Back-to-Back Wins for Jiménez Using Newton Fast Motion

In a further show of validation, Miguel Ángel Jiménez, one of the most accomplished players on the PGA TOUR Champions, signed with Newton earlier this year (https://ibn.fm/dOlWg) — and has since won four PGA TOUR Champions victories (https://ibn.fm/7JVjG). Last month, he won the Kaulig Companies Championship, rallying to force a playoff and winning with a 20-foot birdie putt on the second extra hole. 

Prior to that, he had come out on top at the Principal Charity Classic at the Wakonda Club, the Trophy Hassan II in Morocco and the Hoag Classic in Newport Beach, California 

Jiménez currently leads the PGA TOUR Champions money list (https://ibn.fm/iPmsf), demonstrating the Newton shaft’s impact at the top tier. “Amazing that my game is still nice.” Jimenez said. “I still have a good distance from the tee, my irons are good, they’re sharp, and then [I] still enjoy what I’m doing. That to me is perfect. The only thing is keep counting. I hope it’s not the last one.”

A Lighter, Faster Shaft Built for Control

The Fast Motion shaft — Newton’s newest innovation — is a lighter Tour-proven option built from advanced high-modulus Toray carbon fibers (https://ibn.fm/UOc1o). The shaft reduces weight by ~10 grams vs. the Motion series while maintaining elite control and tight dispersion. Designed for faster swing speeds, the Fast Motion loads naturally for consistent timing and more powerful strikes.

Golf Magazine’s Kris McCormack said it best: “When you start seeing some of the best ball strikers of the last 30 years slotting Newton shafts into the bag, that’s not noise — that’s a signal.”

Innovation Driving Market Success

In fiscal year 2024, Newton Golf reported 887% YoY revenue growth, driven by the success of its proprietary shafts (https://ibn.fm/93tGl). The company’s strategy includes:

• R&D focused on physics-first engineering
• Shafts manufactured in the U.S. for quality control and logistics advantage
• Direct-to-consumer and fitter-driven sales model
• Strong presence across PGA TOUR Champions and growing LPGA adoption.

With more than 50 Tour players trusting Newton shafts and recent victories reinforcing the brand’s performance, Newton Golf is quickly establishing itself as a premier force in the golf-equipment industry.

For more information, visit the company’s website at www.NewtonGolfIR.com.

NOTE TO INVESTORS: The latest news and updates relating to NWTG are available in the company’s newsroom at https://ibn.fm/NWTG

• Izotropic is the only commercial entity with exclusive global rights to the Breast CT technology developed at UC Davis.
• The company has secured regulatory alignment with the FDA and is preparing for a pivotal U.S. clinical trial.
• IzoView offers a proprietary, patient-centric alternative to mammography for dense breast tissue imaging.
• A comprehensive business and financial plan supports execution across clinical, regulatory, and commercial milestones.
• Awareness campaigns, including breastct.com and a company podcast, are primed to drive engagement and investor visibility.

Izotropic (CSE: IZO) (OTCQB: IZOZF) is a medical device company advancing dedicated imaging solutions to improve the screening, diagnosis, and treatment of breast cancer. Focused exclusively on this clinical area, Izotropic is developing purpose-built technologies designed to address persistent limitations in conventional breast imaging. Through innovation in both device architecture and image acquisition, the company aims to enhance diagnostic confidence while improving patient experience.

Izotropic’s mission is to deliver transformative tools that empower radiologists, reduce missed cancers, and streamline clinical workflows. By introducing a next-generation imaging platform for breast cancer screening and diagnosis, the company is targeting a clear unmet need in a multibillion-dollar global market. Its vision centers on redefining how breast imaging is performed—shifting away from adaptations of whole-body scanners or 2D mammography toward a fully dedicated approach optimized for breast anatomy.

The company’s strategy is built around a singular platform with expansion potential. Izotropic is focused on commercializing its lead product through a staged pathway that includes regulatory authorization, clinical validation, and strategic investor engagement. In parallel, the company is developing educational tools and communications platforms to raise awareness among patients, clinicians, and stakeholders about the evolving role of dedicated breast imaging technologies in cancer care.

The company is headquartered in Vancouver, British Columbia, with operations in Sacramento, California.

Technology Portfolio

Izotropic’s flagship product is the IzoView Breast CT Imaging System, a dedicated breast imaging platform offering high-resolution, true 3D visualization without compression. The IzoView system was advanced from academic innovation to commercial readiness by Izotropic’s in-house team, building on exclusively licensed technology developed at the University of California, Davis to optimize diagnostic accuracy, patient comfort, and clinical workflow. IzoView integrates proprietary mechanical design, patented hardware innovations, and trade-secret software algorithms, along with AI-driven enhancements designed to improve radiologist performance.

Now in clinical-ready form and housed at Izotropic’s engineering facility in Sacramento, California, IzoView was built under an ISO 13485-compliant quality management system. It is scheduled for use in the company’s planned U.S. clinical trial for FDA market authorization. The device is also central to the company’s broader commercialization strategy, which includes platform extensions and future imaging-based product lines outlined in its recently completed 150-page business plan and financial model.

In preparation for launch, Izotropic is also rolling out strategic awareness platforms. These include a company-hosted podcast and the development of breastct.com, a new educational resource to support patients, clinicians, and stakeholders. These initiatives are designed to enhance engagement, reinforce brand positioning, and build early market traction for IzoView.

Market Opportunity

Izotropic is targeting the global breast imaging market, which is undergoing rapid innovation as healthcare providers seek more accurate, patient-friendly alternatives to traditional mammography. Current screening technologies have well-documented limitations in detecting tumors in women with dense breast tissue, a challenge IzoView directly addresses.

According to a report by MarketsandMarkets, the breast imaging market is projected to grow from $4.3 billion in 2023 to $6.6 billion by 2028, at a compound annual growth rate (CAGR) of 8.9%. Key drivers include the increasing prevalence of breast cancer, the shift toward early detection, and advances in imaging technology such as AI integration and contrast-enhanced diagnostics.

Izotropic’s licensing structure with UC Davis allows the company to pursue either FDA or CE Mark approval, offering flexibility for U.S. and international market entry. Izotropic’s go-to-market plan is supported by ongoing education efforts and a structured clinical strategy, both aligned to accelerate adoption and unlock value in a growing global market.

Leadership Team

Robert Thast, Interim CEO, is the founding executive of Izotropic and has over 30 years of experience leading public companies. He has raised over $100 million in capital, built cross-functional leadership teams, and guided early-stage ventures through public listings and strategic transitions. At Izotropic, he oversees corporate development, financing, and market strategy.

Dr. John Boone, Ph.D., Principal Founder and Director, is a Distinguished Professor of Radiology and Biomedical Engineering at UC Davis. He is a pioneer in breast CT development, having built and tested four dedicated scanners and led trials with nearly 500 women. He has held top roles in AAPM and RSNA and currently serves as Editor-in-Chief of Medical Physics.

Ralph Proceviat, CPA, CFO and Director, brings more than four decades of experience in finance, restructuring, and cross-border operations. He has served as CEO, President, and CFO across multiple sectors and has raised significant capital for both public and private ventures. He is also the founder of C-Suite-Consulting.

Dr. Younes Achkire, Ph.D., Chief Operating Officer and Lead Engineer, is the technical lead behind IzoView. He previously co-founded Zap Surgical Systems and has commercialized FDA-cleared technologies in medtech and clean energy. At Izotropic, he manages engineering, manufacturing, clinical deployment, and operational scale-up.

For more information, visit the company’s website at https://izocorp.com.

NOTE TO INVESTORS: The latest news and updates relating to IZOZF are available in the company’s newsroom at https://ibn.fm/IZOZF

• The Dominion Creek property lies within a highly prospective ground underlain by the Isaac Lake Fault system.
• Nicola marked a major milestone at Dominion by obtaining the final bulk sample permit from BC authorities, allowing extraction of up to 10,000 tonnes of ore.
• Resource potential at Dominion Creek is supported by historic high-grade production. 

Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF) is steadily advancing its Dominion Creek project in British Columbia’s gold-rich region, integrating gold and silver exploration with nearby milling infrastructure to deliver both resource growth and early-stage production outcomes. The company’s focus on strategic permits, strong assay results and a vertically integrated model underscores its vision of becoming a reliable, cash-flow generating junior miner.

The Dominion Creek property, located 43 kilometers northeast of Wells, lies within a highly prospective ground underlain by the Isaac Lake Fault system (https://ibn.fm/kJ1VH). Nicola holds a 75% economic interest in the project through a combination of land ownership and profit-sharing agreements with High Range Exploration Ltd. The 7.5 km-long claim package hosts high-grade gold-silver veins, with historic sampling revealing standout grades, such as 62.1 g/t Au and 320 g/t Ag from a 9.7 kg surface sample, underscoring the area’s exploration potential (https://ibn.fm/JiVTT).   

In March, Nicola marked a major milestone with the Dominion Creek project by obtaining the final bulk sample permit from the BC government, which will allow Nicola to extract up to 10,000 tonnes of ore (https://ibn.fm/h4km5). A free-use permit accompanying this licence authorizes construction of haulage roads to support future mining activities. This regulatory win positions Nicola to initiate extraction at Dominion Creek, which is the next major step for the company. The company has funded road upgrades via a $50,000 investment to High Range, accelerating progress toward bulk sampling (https://ibn.fm/lvFrS). 

The company plans to transport the high-grade gold ore from the town of Wells to Nicola’s wholly owned Merritt Mill, a fully permitted custom processing facility capable of handling multiple gold-silver feed sources. This mill operation encourages Nicola’s self-sustaining balance sheet, generating cash flow while developing its copper, gold and silver projects. According to a recent Noble Research Report, the company expects Dominion Creek to contribute to the Merritt Mill’s ramp-up in Q3, complementing other ore sources such as Blue Lagoon’s Dome Mountain project (https://ibn.fm/6Vt0y). 

The potential upside at Dominion Creek is worth highlighting. It is supported by a historic 1,180-tonne bulk sample taken in 1992 from the South Zone, which delivered head-grade gold of approximately 14.1 g/t and gold recovery rates near 93% through conventional processing (https://ibn.fm/enaAB). Recent head samples from vein targets such as Number 16 have yielded up to 62.1 g/t Au and 320 g/t Ag, with similar high-grade results (e.g., 58.7 g/t Au, 130 g/t Ag) from concentrates produced in 1989–1992. These grades speak to the high-end potential of Dominion’s mineralization. The project also benefits from established infrastructure, First Nations engagement — including a letter of support from the Lheidli T’enneh — and a bulk-sample permitting process (https://ibn.fm/3LrH2). 

Nicola’s operational blueprint for 2025 includes commencing Dominion Creek’s bulk sample extraction in Q3, reaching and maintaining full-production capacity at the Merritt Mill, and publishing exploration results for the flagship New Craigmont (Copper) Project (https://ibn.fm/U71Qd). Nicola’s strategy synergizes with its broader corporate objectives: To concentrate operations within British Columbia. In tandem with Dominion Creek and New Craigmont, the company is advancing Treasure Mountain, a silver-lead-zinc project (https://ibn.fm/njFlN). The integration of exploration and processing capability enhances Nicola’s sustainability and operational efficiency, positioning itself for further organic growth.

Nicola Mining stands out among other junior miners, especially in BC. Its balanced strategy blends exploration upside with steady cash flow from processing ore. By capturing value from its high-grade gold-silver system, and converting it into tangible ore through a permitted mill, Nicola effectively minimizes dilution and enhances its appeal to investors seeking actionable exposure to resource development in British Columbia.

In summary, Nicola Mining’s Dominion Creek project is entering a new phase, transitioning from exploration to bulk sampling and production. Supported by records of historically high-grade samples, operational permits, and the Merritt Mill, Dominion Creek highlights Nicola’s growing impact on the BC’s mining sector.

For more information, visit www.NicolaMining.com.

NOTE TO INVESTORS: The latest news and updates relating to HUSIF are available in the company’s newsroom at https://ibn.fm/HUSIF 

• Platinum’s unique properties — exceptional conductivity, heat resistance and catalytic efficiency — make it indispensable across a range of electrical applications. 
• Hydrogen fuel cells, particularly the proton exchange membrane variety, are one of the most promising sources of green energy production.
• PLG is a player in this emerging landscape, with a focus on the development of large-scale platinum group metal resources in the Bushveld Complex.

As global industries search for scalable and sustainable energy solutions, platinum has emerged as a critical component in the future of electrical applications. Platinum Group Metals (NYSE American: PLG) (TSX: PTM), is well positioned to help meet this growing demand through its strategic operations in South Africa’s platinum-rich Bushveld Complex.

Platinum’s unique properties — exceptional conductivity, heat resistance and catalytic efficiency — make it indispensable across a range of industrial and electrical applications. From use in hard disk drives and thermocouples to spark plugs and oxygen sensors, platinum has long played a quiet but crucial role in technology and industry. However, the metal’s importance is rapidly evolving beyond conventional applications, thanks to the increasing demand for clean-energy solutions, particularly hydrogen fuel cells, which rely on platinum as a catalyst.

The growth of artificial intelligence has brought platinum into sharper focus as the world grapples with the energy demands of next-generation computing. A report by the Japan Exchange Group explains that training advanced AI models, such as ChatGPT, requires enormous power, with daily electricity consumption equivalent to that of 17,000 average U.S. households (https://ibn.fm/oY3Q1). This level of demand, especially when concentrated in large-scale data centers, presents serious environmental and sustainability challenges. As these AI models become more complex and integrated across industries, the pressure to reduce their carbon footprint is pushing the development of cleaner power alternatives.

One of the most promising of these alternatives is the hydrogen fuel cell, particularly the proton exchange membrane (“PEM”) variety that uses platinum to catalyze an electrochemical reaction between hydrogen and oxygen. Unlike traditional energy sources, hydrogen fuel cells do not rely on combustion and emit no carbon dioxide. Their only byproducts are water and heat (https://ibn.fm/V4Bvv). This makes them especially appealing as a stationary power source for energy-intensive data centers and AI operations. 

“Further, the hydrogen used by fuel cells can be produced through the electrolysis of water, powered by renewable energy sources such as wind and solar, making the energy provided completely fossil free,” reported the Japan Exchange Group. “The WPIC estimates that around a third of the global electrolyser market will rely upon platinum-containing PEM electrolysers.”

Platinum Group Metals is working to be a player in this emerging landscape. The company’s primary focus is the development of large-scale platinum group metal resources in the Bushveld Complex, a region responsible for producing roughly 75% of the world’s platinum supply (https://ibn.fm/VfthP). The company’s flagship project, the Waterberg Project, is one of the newest and largest undeveloped PGM resources in South Africa (https://ibn.fm/UCdzf). It is specifically designed to support low-cost, bulk mechanized mining, ideal for supplying high volumes of platinum to markets increasingly driven by technological and environmental innovation.

Waterberg is also notable for its high palladium content, another metal used in emissions control systems, as well as significant amounts of rhodium and gold. 

Platinum Group Metals continues to advance the Waterberg Project in partnership with leading industry players, including Impala Platinum Holdings Ltd., a major global PGM producer, Japan Organization for Metals and Energy Security and Hanwa Co., Ltd.  This joint venture provides PLG with technical and financial support as it moves toward development.  In addition, PLG and Valterra Platinum Limited are working together through joint venture corporation Lion Battery Technologies Inc. to develop next-generation lithium-sulphur battery technology that incorporates platinum and palladium into new cathode designs aimed at improving battery life, energy density and efficiency.

With rising global awareness around climate change, energy sustainability and the environmental cost of AI technologies, platinum’s relevance in clean, high-performance electrical systems is growing. Platinum Group Metals’ development activities place it at the heart of this transition, helping to supply a metal that is both critical to industry and environmentally beneficial.

For more information, visit www.PlatinumGroupMetals.net.  

NOTE TO INVESTORS: The latest news and updates relating to PLG are available in the company’s newsroom at https://ibn.fm/PLG

• Clene is progressing toward a potential FDA accelerated approval for its ALS (Amyotrophic Lateral Sclerosis) drug CNM-Au8^® in 2026, a market that is expected to reach $1.3 billion by 2034 with significant unmet need.
• Clene’s technology targets mitochondrial dysfunction, a novel approach to neurodegenerative diseases, and key FDA meetings in the coming months of 2025 could be major valuation catalysts for investors.
• Biomarker and survival data from over 150 patients will be critical to the company’s regulatory case and expects important NfL data in the fourth quarter of 2025.
• Clene is preparing to initiate a confirmatory Phase 3 ALS trial in the first half of 2026, with a separate MS (multiple sclerosis) program in late-stage development.

Investors looking for exposure to important biopharma innovation in underserved markets need to consider Clene (NASDAQ: CLNN). Clene and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company is focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). The company is advancing its lead candidate CNM-Au8^®, a unique and needed oral treatment for ALS, toward a potential FDA accelerated approval. 

Clene’s primary value proposition lies in its differentiated mechanism of action and its potential to secure a meaningful share of the large and growing ALS treatment market. CNM-Au8 is a suspension of gold nanocrystals designed to enhance mitochondrial function and protect neurons, an approach that targets the bioenergetic deficits believed to underlie ALS as well as other neurodegenerative diseases. This could be just the beginning. 

The company’s next inflection point is expected in Q4 2025, when it will report neurofilament light chain (“NfL”) biomarker results from over 150 ALS patients treated in the NIH-sponsored Expanded Access Program (“EAP”). Positive results would strengthen Clene’s case for a New Drug Application (“NDA”) under the FDA’s accelerated approval pathway. According to Clene, the FDA has responded constructively and accepted the basis for the company’s revised statistical analysis plan, which was recently resubmitted for final approval (https://ibn.fm/9EM0s).

Benjamin Greenberg, MD, Clene’s Head of Medical, said the FDA’s “constructive feedback” encourages the company to move forward. The company has also scheduled two additional FDA meetings in 3Q 2025: one to discuss long-term survival data from the HEALEY ALS Platform Trial and another to evaluate Phase 2 results from its multiple sclerosis program.

From an investor perspective, these regulatory discussions could unlock significant value for Clene by accelerating CNM-Au8’s path to market. Based on positive NfL results, Clene plans to launch a confirmatory Phase 3 trial, RESTORE-ALS, in the first half of 2026.

The broader market opportunity is also compelling. According to Research and Markets, the global ALS market was valued at $791.90 million in 2024 and is projected to grow at a CAGR of 5.40%, to reach $1.3 billion by 2034, driven by the rising incidence of ALS and aging populations (https://ibn.fm/qmuTf) CNM-Au8, if approved, would be an important addition to only a few commercially available treatments for ALS.

Clene is also advancing a parallel MS program with the same CNM-Au8 drug asset. Clene will meet with FDA in Q3 2025 for its End-of-Phase 2 meeting, planned to pave the way for a Phase 3 trial targeting cognitive improvement in people with MS. Cognitive dysfunction significantly impacts people living with MS, remaining a key unmet need in the treatment of Multiple Sclerosis.

For investors, Clene’s value lies in its multiple shots on goal: regulatory catalysts in both ALS and MS, ongoing data generation, and a novel therapeutic platform. While clinical-stage biotechs carry inherent risks, the company’s unique approach could significantly shorten its path to commercialization and generate early revenue from a patient population with limited options.

Clene’s differentiated technology and advancing clinical programs position it as a company to watch with important investment potential in the evolving neurodegenerative therapy space.

For more information, visit the company’s website at www.Clene.com.

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN